Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve the Audited Standalone ....
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Neuland Laboratories Ltd has informed BSE that a Board meeting is scheduled for May 12, 2026. The meeting will consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. Additionally, the Board will recommend a final dividend for FY 2025-26. The trading window remains closed from April 1, 2026 until 48 hours after the results and dividend declaration. This is a standard regulatory filing announcing the board meeting agenda, with no actual financial results disclosed at this stage.
This is a routine board meeting notice. No investment signals can be derived until the actual financial results are released after the meeting. Shareholders should monitor the May 12 meeting outcome for Q4 and full-year FY26 results and dividend announcements.